Personalized T cell therapy shows signs of clinical effectiveness against HBV-related HCC
April 12, 2018, Paris, France: Multiple adoptive transfers of T cells engineered to carry hepatitis B virus (HBV)-specific T cell receptors (TCRs) has resulted in...